Arrhythmias in COVID-19: New Review Tackles Mechanisms, Management
The virus or its treatments may disrupt heart rhythm, but the immune response and its targets likely deserve the most scrutiny.
The virus or its treatments may disrupt heart rhythm, but the immune response and its targets likely deserve the most scrutiny.
There remains an unmet need for therapies proven to lower the increased CV risk seen in this population.
Compared with patients who fasted, those who didn’t reported a better overall experience with zero safety compromises.
Jagmeet Singh joins Harriette Van Spall to discuss artificial intelligence in the realm of heart failure.
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.
Monika Safford, MD, explains how peer coaching and practice facilitation may improve systolic blood pressure for patients in the US “Black Belt.”
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.